One in Three Retired Football Players Report Perceived Chronic Traumatic Encephalopathy
By Lori Solomon HealthDay Reporter
MONDAY, Sept. 23, 2024 -- More than one-third of living former professional American-style football (ASF) players report perceived chronic traumatic encephalopathy (CTE), which is associated with an increased prevalence of self-reported suicidality, according to a study published online Sept. 23 in JAMA Neurology.
Rachel Grashow, Ph.D., from Harvard University in Boston, and colleagues sought to determine the proportion, clinical correlates, and suicidality of living former professional ASF players with perceived CTE. The analysis included data from 1,980 former professional ASF players (1960 to 2020) participating in the Football Players Health Study at Harvard University (2017 to 2020).
The researchers found that 34.4 percent of participants reported perceived CTE. Factors significantly associated with perceived CTE included subjective cognitive difficulties, low testosterone level, headache, concussion signs and symptoms accrued during playing years, depressive/emotional and behavioral dyscontrol symptoms, pain, and younger age. Suicidality was reported by 25.4 percent of participants with perceived CTE and 5.0 percent of those without perceived CTE. Participants with perceived CTE remained twice as likely to report suicidality (odds ratio, 2.06), even when adjusting for established suicidality predictors (e.g., depression).
"Perceived CTE represents a novel risk factor for suicidality and, if present, should motivate the diagnostic assessment and treatment of medical and behavioral conditions that may be misattributed to CTE neuropathological change," the authors write.
Several authors disclosed ties to the neurodiagnostics industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression
MONDAY, June 16, 2025 -- For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief for...
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.